Plain-English translation of NCT04263935 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lymphoma research guide →Researchers want to understand how specific gene abnormalities in lymphoma cells affect how well treatments work and how the disease progresses over time. This is an observational study, meaning the researchers will collect and analyze existing medical information from lymphoma patients rather than testing a new drug. By studying the connection between gene changes and treatment outcomes, this research may help doctors better predict which treatments will work best for future patients.
Lymphoma is a complex disease, and not all patients respond the same way to the same treatments. Researchers believe that understanding the specific gene abnormalities in each patient's cancer cells could help predict treatment success and improve how doctors personalize care for lymphoma patients.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow the research team to access and review your medical records, including information about your lymphoma diagnosis, treatment history, and any genetic testing results. There are no new medications to take or procedures to undergo — the study simply involves collecting existing medical information and data about your gene abnormalities and how your disease has progressed. Your participation would take place over an extended period as researchers follow your disease course and treatment outcomes.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Sponsor
Henan Cancer Hospital
Enrollment target
~200 participants
Started
January 2019
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yanyan Liu, M.D. Ph.D
Henan Cancer Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.